Publisher： John Wiley & Sons Inc
E-ISSN： 1752-699x|12|2|563-571
ISSN： 1752-6981
Source： THE CLINICAL RESPIRATORY JOURNAL, Vol.12, Iss.2, 2018-02, pp. : 563-571
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Spotlight on Omalizumab in Allergic Asthma
By Lynne M. Bang Greg L. Plosker
BioDrugs, Vol. 18, Iss. 6, 2004-01 ,pp. :
Access to resources
Recommend
Prospects for a Vaccine in Allergic Diseases and Asthma
By Bousquet J. Yssel H. demoly P.
BioDrugs, Vol. 13, Iss. 1, 2000-01 ,pp. :
Respirable Antisense Oligonucleotide (RASON) Therapy for Allergic Asthma
By Metzger W.J.
BioDrugs, Vol. 12, Iss. 4, 1999-10 ,pp. :
Omalizumab: A Review of its Use in the Treatment of Allergic Asthma
By Plosker Greg L. Keam Susan J.
BioDrugs, Vol. 22, Iss. 3, 2008-01 ,pp. :